VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) […]
Following merger with Adaptive Phage Therapeutics in March, combined company reports funding sufficient to support important data readouts for lead […]